The desert tortoise is listed by the United States government as a threatened species in part of its range. A major contributing factor in the decline of this animal has been the presence of an upper respiratory tract disease (URTD) which is characterized by a chronic disease which eventually leads to severe occlusion of the nares with viscous exudate and destruction of the respiratory epithelium. Electron microscopy of infected tissues demonstrated the presence of a mycoplasma-like organism attached to the respiratory surfaces. The mycoplasma was isolated and designated as a new species, with the proposed name Mycoplasma agassizii. The current study was designed to fulfill Koch's postulates and determine if M. agassizii was the etiologic agent of URTD. Clinically healthy animals with known antibody status were infused intranasally with pooled exudate (n = 8) from ill donor animals, with M. agassizii alone (n = 9) or in combination with PasteureUa testudinis (n = 8), with P. testudinis alone (n = 9), or with sterile broth (n = 12). The pooled exudate was culture positive for M. agassizii. Tortoises which received exudate or M. agassizii alone or in conjunction with P. testudinis were significantly more likely to develop clinical disease (P < 0.0004) than animals which received P. testudinis alone or the broth controls. Tortoises demonstrated a strong immune response to M. agassizii, and seroconversion was seen in all groups with clinical disease. M. agassizii was isolated from the upper respiratory tracts of clinically ill animals up to 6 months postinfection. On the basis of the results of these transmission studies, we conclude that M. agassizii is an etiologic agent of URTD in the desert tortoise.
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Dramatic declines in the population of the desert tortoise, Gopherus agassizii, in the western Mojave Desert over the preceding 10 years resulted in designation of the animal by the Fish and Wildlife Service as environmentally threatened in 1990. Although a number of factors including habitat destruction, drought, and predation have contributed to the population decline, the appearance of an upper respiratory tract disease (URTD) was associated with major losses (8, 12) . URTD has been seen in both captive (16) and wild (8) desert tortoises in the southwest United States and by us in captive and wild gopher tortoises (Gopheruspolyphemus) in Florida. A similar disease has been seen in a variety of captive tortoises imported into England (9) and in tortoises submitted to the Veterinary Medical Teaching Hospital, University of Florida, of the following types: red-footed tortoise (Geochelone carbonaria), leopard tortoise (Geochelone pardalis), Indian starred tortoise (Geochelone elegans), and radiated tortoise (Geochelone radiata). In desert tortoises and other tortoises, the disease is seen as a rhinitis characterized by an intermittent serous discharge flowing or bubbling from the nares. On some days the nares will appear dry. As the disease progresses, the discharge becomes more tenacious and contains large numbers of inflammatory cells and bacteria.
Fowler examined desert tortoises with respiratory disease and concluded that no single microorganism was responsible (4) . In his opinion, continued stress, especially resulting from malnutrition, was primarily responsible for the development of the disease. In another study, no major differences were observed in bacterial isolates from the respiratory tracts of captive and free-ranging desert tortoises (16) . A bacterium belonging to the genus Pasteurella was isolated from the respiratory tract of both groups of tortoises, and eventually species status was proposed for these isolates under the name Pasteurella testudinis sp. nov. (15) . Since this microorganism had been isolated from the respiratory tracts of ill and healthy desert tortoises, its significance was unknown.
Rhinitis also has been seen in long-term captive Mediterranean tortoises (Testudo gareca and Testudo hermanni), and a variety of microorganisms have been isolated from both ill and healthy tortoises of these species (9) . As with desert tortoises, no major differences in bacterial isolations were noted. Because in many cases nasal swabs taken from tortoises with rhinitis do not yield bacteria, some investigators have suspected a viral agent as the cause of this disease (7) . In another report, although not isolated from tortoises with rhinitis, mycoplasma was listed as a potential suspect microorganism (9) .
In Tortoises were acclimated for 10 months prior to initiation of the study and allowed to undergo normal hibernation prior to initiation of the transmission study. During the acclimation period, eight tortoises became clinically ill and were removed from the study, one tortoise died, and one tortoise required euthanasia as a result of severe debilitation.
Prior to challenge, each tortoise was restrained manually and 2 ml of blood was collected from the jugular vein. Blood was added to lithium heparin microtainer tubes (Becton Dickinson, Franklin Lakes, N.J.) and inverted gently several times to prevent coagulation. Packed cell volumes were determined on a portion of the sample; the remainder of the blood was centrifuged, and the plasma was removed and frozen in cryotubes in liquid nitrogen for future antibody determinations. The area around the external nares was cleaned with sterile saline. Nasal washes were collected by gently flushing the nares with 1 ml of sterile tryptose broth (Remel Laboratories, Lenexa, Kans.) via a catheter attached to a syringe. Following collection, the nasal washes were placed in cryotubes, frozen in liquid nitrogen, and transported on dry ice to the University of Florida for processing.
Because the antibody level of each animal was known prior to the start of the infection study and because of the limited number of animals available, we were unable to completely randomize treatment. Pen groups with the lowest preexisting levels of antibody to M. agassizii were chosen to receive the critical infections of M. agassizii or P. testudinis.
Infection groups. Treatment groups are summarized in Table 1 . Group I animals (n = 9) received 0.5 ml (0.25 ml per nostril) of M. agassizii grown in SP4 broth (18) to a concentra- b The control group contained tortoises which were infused with 0.5 ml of intranasal sterile TSB used to grow P. testudinis (n = 4), 0.5 ml of intranasal sterile SP4 broth used to grow M. agassizii (n = 3), or no infusion (no intranasal challenge) (n = 5).
tion of 109 color-changing units per ml. The M. agassizii strain used was originally isolated from the nares of a desert tortoise with URTD (8) , was filter cloned, and was two passages from the primary isolation. The purity of the isolate was determined on the basis of immunostaining and 16S rRNA sequence analysis. Group II animals (n = 9) received 0.5 ml (0.25 ml per nostril) of P. testudinis grown in brain heart infusion broth to a concentration of 109 CFU/ml. The P. testudinis strain used was originally isolated from the nares of a desert tortoise with URTD (16) . Group III animals (n = 8) received 0.5 ml (0.25 ml per nostril) of an equal mixture of M. agassizii and P. testudinis. Because of the possibility that an unidentified infectious agent was responsible for the disease, group IV animals (n = 9) received 0.5 ml (0.25 ml per nostril) of exudate (pooled nasal secretions) derived from desert tortoises with active clinical URTD. M. agassizii was cultured from these exudates. Group V animals were control tortoises which received either 0.5 ml (0.25 ml per nostril) of tryptose soy broth (n = 4), SP4 broth (n = 3), or no intranasal challenge of any type (n = 5). For all groups, nasal infusions were performed via a catheter connected to a 1-ml syringe.
One additional group of tortoises (n = 4) in which one animal had high levels of antibodies to M. agassizii but never had any clinical evidence of illness was identified. To determine if this animal was an active carrier, the solid metal barriers separating adjacent pens were removed and tortoises were allowed to have both visual and physical contact through the fencing material. These tortoises did not receive any treatments. Although not technically part of the transmission study, these tortoises were observed for clinical signs and antibody production.
Postinfection monitoring of tortoises. Following infection, all tortoises were observed daily for clinical signs of URTD. Clinical signs of URTD included lethargy, change in behavioral and feeding habits, and physical signs such as runny or wet noses. At 1, 3, and 6 months postinfection, blood was obtained and processed as described above. In tortoises with rhinitis, nasal washings were collected and processed as described above.
Microbial cultures. Nasal washes were received at the ELISA procedure. The enzyme-linked immunosorbent assay (ELISA) procedure was performed as previously described (14) . Briefly, M. agassizii PS6 was grown to mid-logarithmic phase in SP4 broth (18) . Antigen was prepared by lysis of the cells in 0.05 M carbonate buffer, pH 10, for 30 min at 37°C followed by boric acid neutralization. The lysate was adjusted to 100 ,ug of protein per ml and stored at -70°C until use.
Each well of a microtiter plate (Maxisorp F96; Nunc, Kamstrup, Denmark) was coated with 50 ,ul of antigen at a concentration of 10 ,ug/ml in phosphate-buffered saline (PBS) containing 0.02% NaN3 (PBS/A) and incubated at 4°C overnight. The wells were washed four times with PBS/A containing 0.05% Tween 20 (PBSA-T) by an automatic ELISA washer (EAW II; SLT-Labinstruments, 5082 Groedig/Salzburg, Austria) and then blocked with 250 ,u of PBS/A containing 1% bovine serum albumin per well at room temperature for 60 min or at 4°C overnight. After four more washes, 50-,ul samples of plasma diluted 1:2 and 1:10 with PBS/A were added to individual wells in duplicate and incubated at room temperature for 60 min. The wells were washed again as described.
Portions (50 RI) of a biotinylated monoclonal antibody against desert tortoise immunoglobulin Y diluted 1:500 in PBS/A were added to the appropriate wells and incubated at room temperature for 60 min. After four washes, the wells were filled with 50 [lI of alkaline phosphatase-labeled streptavidin (APStreptavidin) (Zymed Laboratories, Inc., San Francisco, Calif.) (1:1,000 dilution in PBS/A) and incubated at room temperature for 60 min. After the wells were washed four times with PBS-T, 50 ,u ofp-nitrophenyl phosphate disodium (Sigma, St. Louis, Mo.) (1 mg/ml prepared in 0.01 M sodium bicarbonate buffer, pH 9.6, containing 2 mM MgCl2) was added to each well and incubated in the dark at room temperature for 60 min. The A405 of each well was determined in an ELISA plate reader (EAR 400 AT; SLT-Labinstruments). In each assay, the blank was the mean of two wells coated with antigen and incubated with the conjugate and the substrate only. Plasma of a desert tortoise, culture negative for M. agassizii and free of lesions indicative of URTD, was the negative control. Plasma from a desert tortoise infected with M. agassizii and having lesions indicative of URTD was the positive control. Positive and negative controls were included on each plate to determine interplate variation. All antibodies used in the ELISA were biotinylated. Antibody levels were expressed as the ratio of the A405 of the sample to the A405 of the negative control (8) .
Pathological evaluations. Representative tortoises (n = 4) from each infection group were euthanatized with a concentrated barbiturate solution and necropsied. The head of each tortoise was bisected longitudinally. Swab specimens of the nasal mucosa were taken for mycoplasmal and microbial Histopathology and lesion analysis. No significant lesions were observed in the control animals. Severe lesions were seen in all tortoises which received exudate (n = 4). In the group which received M agassizii alone, severe lesions were seen in one, moderate lesions were seen in two animals, and mild lesions were seen in one animal. In the group which received both M agassizii and P. testudinis, moderate lesions were observed in all tortoises.
Sections from the mucous and olfactory mucosae of normal control tortoises (Fig. 1) showed occasional small subepithelial lymphoid aggregates. Heterophils were rarely observed in the laminae propriae. No changes in the mucosal or glandular epithelia were noted, and no edema was observed. A lesion was characterized as mild inflammation ( Fig. 2A) if multifocal, small subepithelial lymphoid aggregates were seen, if the lamina propria contained multifocal small numbers of heterophils, lymphocytes, and plasma cells, and if mild edema was seen in the lamina propria and minimal changes were noted in the mucosal epithelium. A lesion was classified as moderate ( Fig. 2B ) if multifocal to focally extensive lymphoid aggregates were observed, if diffuse, moderate numbers of heterophils, lymphocytes, and plasma cells which occasionally infiltrated the overlying mucosal epithelium were seen, and if moderate edema was noted in the lamina propria with proliferation and disorganization of the basal epithelium. A lesion was classed as severe (Fig. 2C) if focally extensive to diffuse bands of lymphocytes and plasma cells subjacent to and obscuring the overlying mucosal epithelium were seen, if large numbers of heterophils were found in the lamina propria and infiltrated the overlying mucosal epithelium, if the lamina propria was characterized by marked edema, if there was degeneration, necrosis, and loss of the mucosal epithelium with occasional erosion, and if proliferation of the basal cells of the epithelium with metaplasia of the mucous and olfactory epithelium to a basaloid epithelium was observed; occasional squamous metaplasia was also noted.
Antibody levels. A significant (P < 0.004) rise in antibody to M agassizii was observed in tortoises receiving exudate as early as 1 month postchallenge (Fig. 3) . Tortoises which received M agassizii alone or in conjunction with P. testudinis also developed an antibody response, but the response was not observed as early as with exudate-challenged animals. By 3 months postinfection, tortoises which received M agassizii (groups I and III, Table 1 ) had significantly higher antibody levels than did animals which received sterile broth (group V) or P. testudinis alone (group II). No difference in levels of antibody between animals receiving M agassizii alone or in concert with P. testudinis was seen; however, tortoises which received the exudate did develop higher responses at 3 months postinfection than did those tortoises which received M agassizii (P < 0.01).
DISCUSSION
Diseases caused by pathogenic microorganisms are an everpresent risk to animals in both captive and wild populations, especially during periods or conditions of captive breeding followed by release or translocation or ecosystem perturbation and habitat loss or fragmentation (6, 10, 11 A major contributing factor in the decline of the desert tortoise and its federal listing as environmentally threatened has been the presence of URTD. Animals have a chronic disease which eventually leads to severe occlusion of the nares with viscous exudate and destruction of the respiratory epithelium (8) . Electron microscopy of infected tissues (8) and association of antibody specific to M. agassizii (14) e s p i r a t o r y epithelium (1, 17) . This is also seen in URTD (8 group IV animals had significantly higher levels than the other groups (P < 0.004). In July and October, antibody levels in animals of groups I, III, and IV were significantly higher than those of animals in other groups (P < 0.004).
experimentally inoculated into the nares of healthy tortoises. Animals challenged with M. agassizii produced antibodies in response to the infection, and M. agassizii was isolated from the nares of animals which became clinically ill. The disease course as well as the specific immune response followed after a reasonable incubation period. Thus, we have fulfilled the majority of Henle-Koch-Evans postulates with regard to this disease. The lesions observed in the experimental infection studies were similar to those observed in the natural disease (8) , and a range of lesions from mild to severe was seen.
A chronic infection was established, as evidenced by isolation of M. agassizii at 1 and 3 months postinfection. We Altematively, loss of virulence after culture in the laboratory could also explain the observed differences in disease severity between the groups. Other factors which could explain the differences in disease severity include a difference between the virulence of the strain used in the study and that of the strain in the donor tortoises, as well as the presence of other contributory factors in the exudate. The exudate undoubtedly contained host inflammatory cells and potentially inflammatory mediators which might enhance the pathogenicity of the mycoplasma.
Antibody profiles demonstrated that the serological test developed may be very helpful in screening for disease. Animals which were challenged responded with a specific antibody response. We do not know the exact temporal sequence of the response, but it appears that in most cases a strong response was developed within 2 months or less of exposure. The response is directed toward a number of mycoplasmal antigens as indicated by Western blot (immunoblot) analysis, and many proteins appear to be shared among different strains of M. agassizii (data not shown).
Most animals with preexisting antibody which developed clinical disease also showed an increase in the amount of specific antibody present (data not shown). However, there were some animals which had levels of preexisting antibody which remained stable even though clinical disease was present. Preexisting antibody did not appear to protect against development of clinical disease in animals challenged intranasally, suggesting that a humoral response alone may not be adequate for protection. There were some animals with stable antibody levels that did not show signs of clinical disease. One of these animals was housed in the communal pen. No other tortoises housed with the antibody-positive tortoise developed antibody or disease. This suggests several interesting possibilities. First, any antibody-positive animal should be considered suspect. Secondly, animals which show increases in antibody over time are likely to be carriers or express disease. Thirdly, some animals may be antibody positive but not spread disease, like the tortoise in the communal pen. This is the first suggestion that some animals can clear M. agassizii from the respiratory tract and recover from, or never get, clinical disease. This issue can be resolved with a more sensitive measurement of microbial presence. A PCR detection system is currently under development in an attempt to address the question of exposure versus infection.
